Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients

Clinical and Experimental Immunology

Volumn 170, Issue 3, 2012, Pages 333-341

  Suchanek, O ^a   Sadler, R ^a   Bateman, E A ^a   Patel, S Y ^a   Ferry, B L ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

B cells; Common variable immunodeficiency (CVID); Diagnostics; Immunodeficiency primary; Immunoglobulins

Indexed keywords

CD20 ANTIGEN; CD27 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M; LEUKOSIALIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; B1 B LYMPHOCYTE; BLOOD; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; AGE FACTORS; AGED; ANTIGENS, CD20; ANTIGENS, CD27; ANTIGENS, CD43; ANTIGENS, CD5; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D; YOUNG ADULT;

EID: 84868261892     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04656.x     Document Type: Article

References (34)

1. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. The 'Ly-1 B' cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med 1983; 157:202-218.
2. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol 2006; 7:293-301.
3. Hayakawa K, Hardy RR, Herzenberg LA. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985; 161:1554-1568.
4. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1989; 1:75-84.
5. Lalor PA, Herzenberg LA, Adams S, Stall AM. Feedback regulation of murine Ly-1 B cell development. Eur J Immunol 1989; 19:507-513.
6. Hayakawa K, Asano M, Shinton SA etal. Positive selection of natural autoreactive B cells. Science 1999; 285:113-116.
7. Zhong X, Gao W, Degauque N etal. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur J Immunol 2007; 37:2400-2404.
8. Kantor AB, Merrill CE, Herzenberg LA, Hillson JL. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 1997; 158:1175-1186.
9. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11:34-46.
10. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-280.
11. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 2000; 97:1184-1189.
12. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011; 208:67-80.
13. Weller S, Braun MC, Tan BK etal. Human blood IgM 'memory' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-3654.
14. Rakhmanov M, Keller B, Gutenberger S etal. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA 2009; 106:13451-13456.
15. Warnatz K, Denz A, Drager R etal. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99:1544-1551.
16. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190-197.
17. Orange JS, Glessner JT, Resnick E etal. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011; 127:1360-1367 e6.
18. Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008; 74:261-271.
19. Mouillot G, Carmagnat M, Gerard L etal. B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010; 30:746-755.
20. Wehr C, Kivioja T, Schmitt C etal. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77-85.
21. Piqueras B, Lavenu-Bombled C, Galicier L etal. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 23:385-400.
22. Ferry BL, Jones J, Bateman EA etal. Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol 2005; 140:532-539.
23. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol 1992; 148:2690-2702.
24. Weller S, Mamani-Matsuda M, Picard C etal. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med 2008; 205:1331-1342.
25. Mackenzie LE, Youinou PY, Hicks R, Yuksel B, Mageed RA, Lydyard PM. Auto- and polyreactivity of IgM from CD5+ and CD5- cord blood B cells. Scand J Immunol 1991; 33:329-335.
26. Lynch EF, Jones PA, Swerdlow SH. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study. Cytometry 1995; 22:223-231.
27. Wilk E, Witte T, Marquardt N etal. Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum 2009; 60:3563-3571.
28. Henry C, Ramadan A, Montcuquet N etal. CD3+CD20+ cells may be an artifact of flow cytometry: comment on the article by Wilk etal. Arthritis Rheum 2010; 62:2561-2563; author reply 3-5.
29. Descatoire MWJ, Reynaud CA, Weller S. A human equivalent of mouse B-1 cells? J Exp Med 2011; 208:2563-2564.
30. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells are CD3-: a reply to 'A human equivalent of mouse B-1 cells?' and 'The nature of circulating CD27+CD43+ B cells'. J Exp Med 2011; 208:2566-2569.
31. Peres-Andres M, Grosserichter-Wagener C, Teodosio C, van Dongen JJ, Orfao A, van Zelm MC. The nature of circulating CD27+CD43+ B cells. J Exp Med 2011; 208:2565-2569.
32. Nisitani S, Murakami M, Akamizu T etal. Preferential localization of human CD5+ B cells in the peritoneal cavity. Scand J Immunol 1997; 46:541-545.
33. Kaminski DA, Stavnezer J. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. J Immunol 2006; 177:6025-6029.
34. Bateman EAL, Ayers L, Sadler R etal. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012; in press.